High prevalence of fosfomycin resistance gene fosA3 in blaCTX-M-harbouring Escherichia coli from urine in a Chinese tertiary hospital during 2010-2014

Epidemiology and Infection

Volumn 145, Issue 4, 2017, Pages 818-824

  Cao, X L ^a   Shen, H ^a   Xu, Y Y ^b   Xu, X J ^a   Zhang, Z F ^a   Cheng, L ^a   Chen, J H ^a   Arakawa, Y ^c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Northern Coal Group General Hospital   (China)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ESBL; Escherichia coli; fosA3; fosfomycin; urinary tract infection

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE CTX-M, E COLI; ESCHERICHIA COLI PROTEIN; FOSA(3) PROTEIN, E COLI;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLA CTX M GENE; CHINA; CLONAL EVOLUTION; CONTROLLED STUDY; ESCHERICHIA COLI; FOSA1 GENE; FOSA3 GENE; HUMAN; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY CARE CENTER; URINE SAMPLING; ANALYSIS; BACTERIUM CONJUGATION; CLASSIFICATION; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI INFECTIONS; GENETIC VARIATION; GENETICS; GENOTYPE; HORIZONTAL GENE TRANSFER; ISOLATION AND PURIFICATION; MICROBIOLOGY; URINARY TRACT INFECTIONS; URINE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHINA; CONJUGATION, GENETIC; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FOSFOMYCIN; GENE TRANSFER, HORIZONTAL; GENETIC VARIATION; GENOTYPE; HUMANS; MULTILOCUS SEQUENCE TYPING; PLASMIDS; PREVALENCE; TERTIARY CARE CENTERS; URINARY TRACT INFECTIONS; URINE;

EID: 85004038661     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268816002879     Document Type: Article

References (37)

1. Jean SS, et al. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013. International Journal of Antimicrobial Agents 2016; 47: 328-334.
2. Martirosov DM, Lodise TP. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae. Diagnostic Microbiology and Infectious Disease 2016; 85: 266-275.
3. Bergen PJ, et al. 'Old' antibiotics for emerging multidrug-resistant bacteria. Current Opinion in Infectious Diseases 2012; 25: 626-633.
4. Falagas ME, et al. Fosfomycin. Clinical Microbiology Reviews 2016; 29: 321-347.
5. Wachino J, et al. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmidmediated fosfomycin-modifying enzymes. Antimicrobial Agents and Chemotherapy 2010; 54: 3061-3064.
6. Neuner EA, et al. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrobial Agents and Chemotherapy 2012; 56:5744-5748.
7. Takahata S, et al. Molecular mechanisms of fosfomycin resistance in clinical isolates of Escherichia coli. International Journal of Antimicrobial Agents 2010; 35: 333-337.
8. Chen C, et al. Prevalence of the fosfomycin-resistance determinant, fosB3, in Enterococcus faecium clinical isolates from China. Journal of Medical Microbiology 2014; 63: 1484-1489.
9. Kitanaka H, et al. Novel integron mediated fosfomycin resistance gene fosK. Antimicrobial Agents and Chemotherapy 2014; 58: 4978-4979.
10. Wang Y, et al. Identification of a novel osXCC gene conferring fosfomycin resistance in Campylobacter. Journal of Antimicrobial Chemotherapy 2015; 70: 1261-1263.
11. Ma Y, et al. Characterization of fosA5, a new plasmidmediated fosfomycin resistance gene in Escherichia coli. Letters in Applied Microbiology 2015; 60: 259-264.
12. Clinical and Laboratory Standards Institute (CLSI). 24th Informational Supplement, M100-S24. Performance Standards for Antimicrobial Susceptibility Testing. CLSI; Wayne, PA: 2014.
13. Dallenne C, et al. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 2010; 65: 4905.
14. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Applied and Environmental Microbiology 2000; 66: 4555-4558.
15. Ribot EM, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathogend and Disease 2006; 3: 59-67.
16. Wang M, et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrobial Agents and Chemotherapy 2003; 47: 2242-2248.
17. Carattoli A, et al. Identification of plasmids by PCRbased replicon typing. Journal of Microbiological Methods 2005; 63: 219-228.
18. Lai B, et al. In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004-2012). BMC Infectious Diseases 2014; 14: 66.
19. Wang Q, et al. Antimicrobial resistance monitoring of gram-negative bacilli isolated from 15 teaching hospitals in 2014 in China. Zhonghua Nei Ke Za Zhi 2015; 54: 837-845.
20. Ghafourian S, et al. Extended spectrum beta-lactamases: definition, classification and epidemiology. Current Issues in Molecular Biology 2015; 17: 11-21.
21. He D, et al. CTX-M-123, a novel hybrid of the CTX-M-1 and CTX-M-9 group β-lactamases recovered from Escherichia coli isolates in China. Antimicrobial Agents and Chemotherapy 2013; 57: 4068-4071.
22. Ahmed AM, Shimamoto T, Shimamoto T. Molecular characterization of multidrug-resistant avian pathogenic Escherichia coli isolated from septicemic broilers. International Journal of Medical Microbiology 2013; 303: 475-483.
23. Sato N, et al. First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan. Microbial Drug Resistance 2013; 19: 477-482.
24. Lee SY, et al. Prevalence of acquired fosfomycin resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. Journal of Antimicrobial Chemotherapy 2012; 67: 2843-2847.
25. Ho PL, et al. Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. Journal of Medical Microbiology 2013; 62: 1707-1713.
26. Hou J, et al. Dissemination of the fosfomycin resistance gene fosA3 with CTX-M beta-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrobial Agents and Chemotherapy 2012; 56: 2135-2138.
27. Cao X, et al. Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals. Journal of Clinical Microbiology 2011; 49: 2496-2501.
28. Navidinia M, et al. Phylogenetic grouping and pathotypic comparison of urine and fecal Escherichia coli isolates from children with urinary tract infection. Brazilan Journal of Microbiology 2014; 45: 509-514.
29. Jakobsen L, Hammerum AM, Frimodt-Møller N. Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, communitydwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model. Applied and Environmental Microbiology 2010; 76: 8281-8284.
30. López-Cerero L, et al. Characterization of clinical and food animal Escherichia coli isolates producing CTXM-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A. International Journal of Antimicrobial Agents 2011; 37: 365-367.
31. Osugui L, et al. Virulence genotypes, antibiotic resistance and the phylogenetic background of extraintestinal pathogenic Escherichia coli isolated from urinary tract infections of dogs and cats in Brazil. Veterinary Microbiology 2014; 171: 242-247.
32. Yang X, et al. F33: A-: B-, IncHI2/ST3, and IncI1/ST71 plasmids drive the dissemination of fosA3 and bla CTXM-55/-14/-65 in Escherichia coli from chickens in China. Frontiers in Microbiology 2014; 5: 688.
33. Ho PL, et al. Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrugresistant Escherichia coli from livestock and other animals. Journal of Applied Microbiology 2013; 114: 695-702.
34. Jiang Y, et al. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China. International Journal of Antimicrobial Agents 2015; 45: 66-70.
35. Li G, et al. First report of a clinical, multidrug-resistant Enterobacteriaceae isolate coharboring fosfomycin resistance gene fosA3 and carbapenemase gene blaKPC-2 on the same transposon, Tn1721. Antimicrobial Agents and Chemotherapy 2015; 59: 338-343.
36. He L, et al. Complete nucleotide sequence of pHN7A8, an F33:A-:B-type epidemic plasmid carrying blaCTXM-65, fosA3 and rmtB from China. Journal of Antimicrobial Chemotherapy 2013; 68: 46-50.
37. Xiang DR, et al. Complete sequence of a novel IncRF33: A-:B-plasmid, pKP1034, harboring fosA3, blaKPC-2, blaCTX-M-65, blaSHV-12, and rmtB from an epidemic Klebsiella pneumoniae sequence Type 11 strain in China. Antimicrobial Agents and Chemotherapy 2015; 60: 1343-1348.